Decoy Therapeutics Ownership | Who Owns Decoy Therapeutics?

Decoy Therapeutics Ownership Summary

Decoy Therapeutics is owned by 0.33% institutional investors, 0.59% insiders, and 99.08% retail investors. Advisory services network is the largest institutional shareholder, holding 0% of DCOY shares. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.76% of its assets in Decoy Therapeutics shares.

DCOY Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Decoy Therapeutics	0.33%	0.59%	99.08%
Sector	Healthcare Stocks	35.56%	12.08%	52.36%
Industry	Biotech Stocks	35.43%	12.01%	52.56%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Advisory services network	-	-	-
Morgan stanley	-	-	-

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Advisory services network	-	-	-
Morgan stanley	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Morgan stanley	-	-	-1.00
Advisory services network	-	-	-41.00

Top Sellers

Holder	Shares	% Assets	Change
Advisory services network	-	-	-41.00
Morgan stanley	-	-	-1.00

Sold Out

Holder	Change
Morgan stanley	-1.00
Advisory services network	-41.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	4	-	1,609	-	-	-	4	-	-	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Institutional Extnd Mkt Idx Tr	4.03K	0.76%	-
Fidelity Extended Market Index	2.90K	0.55%	-2.25K
Spartan Extended Market Index Pool F	1.28K	0.24%	-
Fidelity Series Total Market Index	477.00	0.09%	-
Spartan Total Market Index Pool G	169.00	0.03%	-
Spartan Total Market Index Pool A1	169.00	0.03%	-
Horizon Kinetics Medical ETF	21.00	0.00%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 30, 2025	HANISH ARNOLD C	-	Sell	$7.68
Dec 30, 2025	HANISH ARNOLD C	-	Sell	$9.60
Nov 20, 2025	HANISH ARNOLD C	-	Buy	$3.74K
Nov 20, 2025	Rosenblum Mark J	Exec VP Finance, CFO	Buy	$16.00K
Jun 07, 2022	Burleson Tess		Buy	$4.99K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	1	-
2024 Q2	-	-
2024 Q1	-	-
2023 Q1	-	-
2022 Q4	-	-

DCOY Ownership FAQ

Who Owns Decoy Therapeutics?

Decoy Therapeutics shareholders are primarily institutional investors at 0.33%, followed by 0.59% insiders and 99.08% retail investors. The average institutional ownership in Decoy Therapeutics's industry, Biotech Stocks , is 35.43%, which Decoy Therapeutics falls below.

Does Blackrock own Decoy Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Decoy Therapeutics.

Who is Decoy Therapeutics’s biggest shareholder by percentage of total assets invested?

Advisory services network is Decoy Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Decoy Therapeutics shares, valued at 0$.

Who is the top mutual fund holder of Decoy Therapeutics shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Decoy Therapeutics shares, with 0.76% of its total shares outstanding invested in 4.03K Decoy Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools